The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Whole-slide multiplexed tissue imaging of prostate adenocarcinoma to investigate  immune niches in high- versus low-grade tumors.
 
Ali Amiryousefi
No Relationships to Disclose
 
Jeremiah Wala
Stock and Other Ownership Interests - nference
 
Brian Labadie
No Relationships to Disclose
 
Aishwarya Atmakuri
No Relationships to Disclose
 
Kiranj Chaudagar
No Relationships to Disclose
 
Eamon Toye
No Relationships to Disclose
 
Andréanne Gagné
No Relationships to Disclose
 
Jia-Ren Lin
No Relationships to Disclose
 
Eliezer Van Allen
Stock and Other Ownership Interests - ervaxx; Genome Medical; Genomic Life; Manifold Bio; Microsoft; Monte Rosa Therapeutics; Riva Therapeutics; Serinus Bio; Syapse; Tango Therapeutics
Consulting or Advisory Role - ervaxx; Genome Medical; Genomic Life; Illumina; Janssen; Manifold Bio; Monte Rosa Therapeutics; Novartis; Riva Therapeutics; Serinus Bio; Syapse; Tango Therapeutics
Speakers' Bureau - Illumina
Research Funding - Bristol-Myers Squibb; Novartis; Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Patent on clinical interpretation algorithms using cancer molecular data (Inst); Patent on discovery of chromatin regulators as biomarkers of response to cancer immunotherapy (Inst); Patent on discovery of retained intron as source of cancer neoantigens (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Akash Patnaik
Stock and Other Ownership Interests - Gilead Sciences; Infinity Pharmaceuticals; Merck; Merck
Honoraria - BostonGene; Medscape; Prime Oncology
Consulting or Advisory Role - Curio Science; Exelixis; Gerson Lehrman Group; Guidepoint Pharmacy
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Laekna Health Care (Inst); Progenics (Inst); Xencor (Inst); Zenith Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Exelixis; Prime Oncology
 
Peter Sorger
Leadership - Applied BioMath; Flagship Pioneering; Glencoe Software; NanoString Technologies; RareCyte
Stock and Other Ownership Interests - Applied BioMath; Glencoe Software; RareCyte
Honoraria - Novartis
Consulting or Advisory Role - Merck
Research Funding - Merck (Inst)